Can I read Neonatal Cardiac Arrest Following Lacosamide Treatment: A Case Report on EtoBox?

Neonatal Cardiac Arrest Following Lacosamide Treatment: A Case Report by Melissa Ann Huberman; Carolina Mallar; Paige M. Kalika is a Medicine article available to read on EtoBox.

What is Neonatal Cardiac Arrest Following Lacosamide Treatment: A Case Report about?

Background: Lacosamide is an antiepileptic drug with US Food and Drug Administration approval for the treatment of partial-onset seizures in patients older than one month. Lacosamide works by selective enhancement of proteins that induce preferential slow promotion of sodium channels to the hyperpolarized inactive state. Lacosamide is generally well-tolerated; however, clinical and nonclinical studies have linked its use with cardiac side effects including PR prolongation and atrioventricular (AV) block. Results: We present the case of a three-week-old female neonatal patient born at 25 weeks' gestation who developed second-degree AV heart block and cardiac arrest after initiating lacosamide therapy. The patient was being treated for neonatal seizure complicated by intraventricular hemorrhage (grade II) and electrolyte disturbances with phenobarbital, levetiracetam, and phenytoin. Before addition of lacosamide therapy, the patient had an unremarkable electrocardiogram and no known cardiac risk factors for lacosamide. After medication discontinuation, the patient experienced no reoccurring episodes or other cardiac events. Conclusion: Use of lacosamide for neonatal populations is cu

Who reads Neonatal Cardiac Arrest Following Lacosamide Treatment: A Case Report?

Author

Melissa Ann Huberman; Carolina Mallar; Paige M. Kalika

Publisher

Elsevier BV

Published

2023

Language

EN

Field

Medicine (Health Sciences)